Cargando…

Correction: Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313866/ https://www.ncbi.nlm.nih.gov/pubmed/34396130 http://dx.doi.org/10.1136/bmjno-2020-000096corr1

Ejemplares similares

Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis
por: Karunaratne, Kushan, et al.
Publicado: (2021)

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
por: Milo, Ron, et al.
Publicado: (2016)

Overlapping anti-NMDAR encephalitis and multiple sclerosis: A case report and literature review
por: Liu, Pan, et al.
Publicado: (2023)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis
por: Reardon, Jennifer, et al.
Publicado: (2013)

Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity
por: Tominaga, Naomi, et al.
Publicado: (2018)

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
por: Cohan, Stanley
Publicado: (2016)

Neuroleptic intolerance in patients with anti-NMDAR encephalitis
por: Lejuste, Florian, et al.
Publicado: (2016)

GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
por: Luessi, Felix, et al.
Publicado: (2018)

Psychiatric manifestations of anti-NMDAR encephalitis
por: Martins, D., et al.
Publicado: (2021)

Molecular Pathogenesis of Anti-NMDAR Encephalitis
por: Ding, Hao, et al.
Publicado: (2015)

The Chinese experience with anti-NMDAR encephalitis
por: Desestret, Virginie
Publicado: (2020)

Anti-NMDAR encephalitis for psychiatrists: the essentials
por: Beattie, Matthew, et al.
Publicado: (2022)

Isolated Memory Loss in Anti-NMDAR Encephalitis
por: Iorio, Raffaele, et al.
Publicado: (2021)

353. HSV-Induced Anti-NMDAR Encephalitis
por: Sahar, Najmus
Publicado: (2018)

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2018)

Clinical Characteristics and Follow-Up of Seizures in Children With Anti-NMDAR Encephalitis
por: Zhang, Jianzhao, et al.
Publicado: (2022)

CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis
por: Desestret, Virginie, et al.
Publicado: (2015)

Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2013)

A peculiar case of psychosis: anti-NMDAr encephalitis
por: Kouba, Lamia, et al.
Publicado: (2021)

Anti-NMDAR limbic encephalitis- a clinical curiosity
por: Kattepur, Abhay K, et al.
Publicado: (2014)

A Young Man with Anti-NMDAR Encephalitis following Guillain-Barré Syndrome
por: Tojo, Kana, et al.
Publicado: (2011)

A case of GFAP-IgG positivity followed by anti-NMDAR encephalitis
por: Zhang, Jia, et al.
Publicado: (2022)

Validation of the NEOS score in Chinese patients with anti-NMDAR encephalitis
por: Peng, Yujing, et al.
Publicado: (2020)

Spectrum and Evolution of EEG Changes in Anti-NMDAR Encephalitis
por: Viswanathan, Lakshminarayanapuram Gopal, et al.
Publicado: (2021)

First Bahraini adolescent with anti-NMDAR-Ab encephalitis
por: Almuslamani, Ahood, et al.
Publicado: (2015)

Anti NMDAR encephalitis masked by symptoms of postpartum depression
por: Milanovic Hromin, S., et al.
Publicado: (2023)

Anti–NMDAR encephalitis in a patient with Crohn disease receiving adalimumab
por: Noble, Geoffrey P., et al.
Publicado: (2018)

A probable case of anti-NMDAR encephalitis from 1830
por: Dalmau, Josep
Publicado: (2020)

Clinical significance of soluble adhesion molecules in anti‐NMDAR encephalitis patients
por: Ding, Yuewen, et al.
Publicado: (2019)

Thyroid Function and Anti-thyroid Antibodies in Pediatric Anti-NMDAR Encephalitis
por: Chen, Lianfeng, et al.
Publicado: (2021)

Anti-NMDAR encephalitis, a mimicker of acute infectious encephalitis and a review of the literature
por: Wong, Darren, et al.
Publicado: (2014)

Ictal and interictal FDG-PET in anti–NMDAR encephalitis with mutism
por: Abou Khaled, Karine J., et al.
Publicado: (2021)

Extreme delta brush in anti‐NMDAR encephalitis: Mimics and chameleons
por: Neshige, Shuichiro, et al.
Publicado: (2021)

Autism Associated With Anti-NMDAR Encephalitis: Glutamate-Related Therapy
por: Tzang, Ruu-Fen, et al.
Publicado: (2019)

First report of concomitant cryptococcal meningitis and anti-NMDAR encephalitis
por: Valdoleiros, Sofia R., et al.
Publicado: (2020)

Characteristics and Outcomes of Paroxysmal Sympathetic Hyperactivity in Anti-NMDAR Encephalitis
por: Chen, Zhongyun, et al.
Publicado: (2022)

Catatonia in adult anti-NMDAR encephalitis: an observational cohort study
por: Wu, Huiting, et al.
Publicado: (2023)

Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis
por: Shin, Yong‐Won, et al.
Publicado: (2018)

Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis
por: Feng, Jingjing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6sn3oouqpiknl5ic0os14am3um